BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15142728)

  • 1. Fabrication and characterization of bioactive wollastonite/PHBV composite scaffolds.
    Li H; Chang J
    Biomaterials; 2004 Nov; 25(24):5473-80. PubMed ID: 15142728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication, characterization, and in vitro degradation of composite scaffolds based on PHBV and bioactive glass.
    Li H; Du R; Chang J
    J Biomater Appl; 2005 Oct; 20(2):137-55. PubMed ID: 16183674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of bioactive and biodegradable wollastonite/poly(D,L-lactic acid) composite scaffolds.
    Li H; Chang J
    J Mater Sci Mater Med; 2004 Oct; 15(10):1089-95. PubMed ID: 15516869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of bioactive mesoporous wollastonite - Polycaprolactone composite scaffold.
    Wei J; Chen F; Shin JW; Hong H; Dai C; Su J; Liu C
    Biomaterials; 2009 Feb; 30(6):1080-8. PubMed ID: 19019424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres.
    Li H; Chang J
    J Control Release; 2005 Oct; 107(3):463-73. PubMed ID: 16154657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication and characterization of polysulfone-dicalcium silicate composite films.
    Cheng W; Chang J
    J Biomater Appl; 2006 Apr; 20(4):361-76. PubMed ID: 16443620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of bioactive collagen/wollastonite composite scaffolds.
    Li X; Chang J
    J Mater Sci Mater Med; 2005 Apr; 16(4):361-5. PubMed ID: 15803282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of wollastonite on proliferation and differentiation of human bone marrow-derived stromal cells in PHBV/wollastonite composite scaffolds.
    Li H; Zhai W; Chang J
    J Biomater Appl; 2009 Sep; 24(3):231-46. PubMed ID: 18987024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior.
    Li X; Shi J; Dong X; Zhang L; Zeng H
    J Biomed Mater Res A; 2008 Jan; 84(1):84-91. PubMed ID: 17600329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro biocompatibility assessment of PHBV/Wollastonite composites.
    Li H; Zhai W; Chang J
    J Mater Sci Mater Med; 2008 Jan; 19(1):67-73. PubMed ID: 17577632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel bioactive porous CaSiO3 scaffold for bone tissue engineering.
    Ni S; Chang J; Chou L
    J Biomed Mater Res A; 2006 Jan; 76(1):196-205. PubMed ID: 16265636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro hydroxyapatite forming ability and dissolution of tobermorite nanofibers.
    Lin K; Chang J; Cheng R
    Acta Biomater; 2007 Mar; 3(2):271-6. PubMed ID: 17234465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of macroporous chitosan/wollastonite composite scaffolds for tissue engineering.
    Zhao L; Chang J
    J Mater Sci Mater Med; 2004 May; 15(5):625-9. PubMed ID: 15386972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication of fibrous poly(butylene succinate)/wollastonite/apatite composite scaffolds by electrospinning and biomimetic process.
    Zhang D; Chang J; Zeng Y
    J Mater Sci Mater Med; 2008 Jan; 19(1):443-9. PubMed ID: 17607518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-CaSiO3/beta-Ca3(PO4)2 composite materials for hard tissue repair: in vitro studies.
    Ni S; Lin K; Chang J; Chou L
    J Biomed Mater Res A; 2008 Apr; 85(1):72-82. PubMed ID: 17688291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of wollastonite-poly(ethylmethacrylate co-vinylpyrrolidone) based materials for multifunctional devices.
    Rodríguez-Lorenzo LM; Carrodeguas RG; Rodríguez MA; De Aza S; Parra J; Román JS
    J Biomed Mater Res A; 2007 Jun; 81(3):603-10. PubMed ID: 17187391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro bioactivity and degradation of polycaprolactone composites containing silicate fillers.
    Chouzouri G; Xanthos M
    Acta Biomater; 2007 Sep; 3(5):745-56. PubMed ID: 17392042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of hydroxyapatite/poly(ethylene glutarate) biomaterials.
    Siriphannon P; Monvisade P; Jinawath S; Hemachandra K
    J Biomed Mater Res A; 2007 May; 81(2):381-91. PubMed ID: 17542004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and antibacterial properties of plasma sprayed wollastonite coatings grafting gentamicin loaded collagen.
    Li B; Liu X; Cao C; Dong Y; Wang Z; Ding C
    J Biomed Mater Res A; 2008 Oct; 87(1):84-90. PubMed ID: 18085657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Mn-Zn ferrite on apatite-wollastonite glass-ceramic (A-W GC).
    Da Li G; Zhou da L; Pan TH; Chen GS; Lin Y; Mao M; Yan G
    Biomed Mater; 2009 Aug; 4(4):045001. PubMed ID: 19525575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.